Atlas Trials

A Randomized Double Dummy Double Blind Dose Determining Place-bo Controlled Study to Evaluate Efficacy of Investigational Product E-RH-06 at 2 Dose Levels for the Metabolic Management of Chronic or Recurrent, Non-infective Nasal Congestion With-or-without Rhinorrhea.

Clinical trial NCT01546662 · UNKNOWN

Trial details

NCT number
NCT01546662
Sponsor
Enovate Biolife Pvt Ltd
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Chronic Rhinitis
Start date
2011-10-01
Primary completion
2012-05-01
Enrollment
54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.